Thurston Springer Miller Herd & Titak’s Bristol-Myers Squibb BMY Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$150K	Buy	2,607 +1,027	+65%	+$59K	0.05%	290
2026 Q1	$95.9K	Sell	1,580 -207	-12%	-$12.1K	0.04%	394
2025 Q4	$96.4K	Buy	1,787 +1,747	+4,368%	+$84K	0.03%	369
2025 Q3	$1.8K	Sell	40 -9,064	-100%	-$423K	﹤0.01%	480
2025 Q2	$422K	Buy	9,104 +2,042	+29%	+$100K	0.05%	263
2025 Q1	$431K	Buy	7,062 +1,246	+21%	+$72.6K	0.07%	210
2024 Q4	$329K	Buy	5,816 +1,284	+28%	+$71.7K	0.07%	215
2024 Q3	$235K	Buy	4,532 +840	+23%	+$39.4K	0.06%	270
2024 Q2	$153K	Buy	+3,692	New	+$165K	0.05%	343

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's BMY Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Bristol-Myers Squibb (BMY) stake by 65% in Q2 2026, buying an estimated $59K and bringing the position to 2,607 shares worth $150K. The position accounts for 0.05% of the portfolio, ranked #290.

Thurston Springer Miller Herd & Titak first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $431K in Q1 2025. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Thurston Springer Miller Herd & Titak held 2,607 shares of Bristol-Myers Squibb worth $150K as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 1,027 Bristol-Myers Squibb shares in Q2 2026, an estimated $59K.
Bristol-Myers Squibb made up 0.05% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #290 holding.
Thurston Springer Miller Herd & Titak first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's Bristol-Myers Squibb position peaked at $431K in Q1 2025.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.